- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 5, 2025 | 48.92M sh |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $29.4B |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $25.76B |
| Total Assets | Q2 2025 · Mar 31, 2025 | $31.28B |
| Total Assets | Q2 2025 · Sep 30, 2024 | $27.47B |
| Operating Income | Q2 2025 · Mar 31, 2025 | −$8.6M |
| Operating Income | Q2 2025 · Mar 31, 2025 | −$29.7M |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$12.8M |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$28.4M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $1.27B |
| Cash And Equivalents | Q2 2025 · Mar 31, 2024 | $1.31B |
| Shares Diluted restated | Q2 2025 · Mar 31, 2024 | 47.25M sh |
| Shares Diluted restated | Q2 2025 · Mar 31, 2024 | 47.06M sh |
| Capex | Q2 2025 · Mar 31, 2024 | $30.1M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $936.4M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $1.54B |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $1.48B |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $1.38B |
| Eps Diluted restated | Q2 2025 · Mar 31, 2024 | $1.09 |
| Eps Diluted restated | Q2 2025 · Mar 31, 2024 | $2.51 |
| Eps Basic restated | Q2 2025 · Mar 31, 2024 | $1.12 |
| Eps Basic restated | Q2 2025 · Mar 31, 2024 | $2.59 |
| Net Income | Q2 2025 · Mar 31, 2024 | $53.1M |
| Net Income | Q2 2025 · Mar 31, 2024 | $122.2M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $818.2M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $1.6B |
| Revenue | Q2 2025 · Mar 31, 2024 | $509.2M |
| Revenue | Q2 2025 · Mar 31, 2024 | $1.14B |